Baird Financial Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Baird Financial Group's HALO Position: Q2 2026 in Review
Baird Financial Group increased its Halozyme (HALO) stake by 3.7% in Q2 2026, buying an estimated $26.8K and bringing the position to 11,087 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.
Baird Financial Group first reported a position in HALO in Q2 2020 and has held it in 24 quarters since. The position peaked at $4.72M in Q4 2023. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Baird Financial Group held 11,087 shares of Halozyme worth $868K as of Q2 2026.
- Baird Financial Group bought 393 Halozyme shares in Q2 2026, an estimated $26.8K.
- Halozyme made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1374 holding.
- Baird Financial Group first reported a position in Halozyme in Q2 2020 and has held it in 24 quarters since.
- Baird Financial Group's Halozyme position peaked at $4.72M in Q4 2023.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.